EUVIMEDEUVIMED entdecken
Crossref

Meropenem-driven amplification of blaAFM-1 leads to high-level cefiderocol resistance in difficult-to-treat Pseudomonas aeruginosa

Hanxu Hong, Ting Zhang, Yang Liu

Drug Resistance Updates · 2026

DOI: 10.1016/j.drup.2026.101419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2026. Verfasst von Hanxu Hong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 17 Yongwai Zhengjie, Nanchang 330006,…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, beta-Lactamases, Cefiderocol, Gene Amplification. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, Health Commission of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cefiderocol (FDC) is a last-resort antibiotic against carbapenem-resistant Pseudomonas aeruginosa, yet mechanisms underlying high-level resistance remain unclear. Here, we report that meropenem exposure induces dynamic tandem amplification of blaAFM-1, leading to markedly increased FDC resistance. This amplification occurs without changes in plasmid copy number and declines without antibiotic pressure, highlighting a clinically relevant pathway of indirect resistance selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial Agentsbeta-LactamasesCefiderocolGene AmplificationMeropenemPseudomonas aeruginosaPseudomonas InfectionsHumansDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsPlasmidsThienamycins

Stichwörter der Autor:innen

AFM-1CefiderocolGene amplificationHigh-level resistancePseudomonas aeruginosa

Substanzen

Anti-Bacterial Agentsbeta-LactamasesCefiderocolMeropenemThienamycins

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 17 Yongwai Zhengjie, Nanchang 330006, China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China; Department II of Respiratory and Critical Care Medicine, Jiangxi Provin…
  • Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 17 Yongwai Zhengjie, Nanchang 330006, China; Jiangxi Medical Center for Critical Public Health Events, The…

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangxi Province
  • Health Commission of Jiangxi Province

Zitieren

APA

Hong, H., Zhang, T., & Liu, Y. (2026). Meropenem-driven amplification of blaAFM-1 leads to high-level cefiderocol resistance in difficult-to-treat Pseudomonas aeruginosa. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101419

Vancouver

Hong H, Zhang T, Liu Y. Meropenem-driven amplification of blaAFM-1 leads to high-level cefiderocol resistance in difficult-to-treat Pseudomonas aeruginosa. Drug Resistance Updates. 2026. doi:10.1016/j.drup.2026.101419

BibTeX
@article{Hong2026,
  author = {Hong, Hanxu and Zhang, Ting and Liu, Yang},
  title = {Meropenem-driven amplification of blaAFM-1 leads to high-level cefiderocol resistance in difficult-to-treat Pseudomonas aeruginosa},
  journal = {Drug Resistance Updates},
  year = {2026},
  doi = {10.1016/j.drup.2026.101419}
}
Kostenlos starten →